hydroxyproline has been researched along with Pneumonia in 47 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Also, the effects of Pirfenidone on macrophage polarization and pulmonary fibrosis were evaluated in silicosis with early intervention and late treatment by histological examination, Enzyme-linked immunosorbent assay, Hydroxyproline assay, Western blot and Quantitative reverse transcription polymerase chain reaction." | 8.12 | Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling pathways. ( Bo, C; Jia, Q; Li, M; Tang, Q; Xing, C; Zhang, Z, 2022) |
| "In this study we investigated the protective effects and possible mechanisms of pirfenidone (PF) in paraquat (PQ)-induced lung injury and fibrosis in mice." | 7.88 | Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression. ( Ghazi-Khansari, M; Heidari, MR; Iranpour, M; Mandegary, A; Pourgholamhossein, F; Pourgholi, L; Pournamdari, M; Poursalehi, HR; Rasooli, R; Samareh-Fekri, M, 2018) |
| "Metabolites of arachidonic acid such as prostacyclin (PGI2) have been shown to participate in the pathogenesis of pulmonary fibrosis by inhibiting the expression of pro-inflammatory and pro-fibrotic mediators." | 7.76 | A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice. ( Gao, J; Guo, Z; Huang, K; Jiang, L; Liu, Y; Xiang, R; Xiao, Y; Zhou, W; Zhu, Y, 2010) |
| " Additionally, FcεRI-deficient mice showed a significantly lower score of pulmonary fibrosis than wild-type mice following exposure to silica, with significantly lower hydroxyproline content and expression of fibrotic genes Col1a1 and Fn1." | 4.12 | FcεRI deficiency alleviates silica-induced pulmonary inflammation and fibrosis. ( Chen, Y; Hou, L; Hu, H; Jiang, X; Li, Z; Pang, J; Song, M; Wang, C; Wang, J; Yang, J; Yang, P; Zhang, H; Zhang, T; Zhang, Z; Zou, X, 2022) |
| " Also, the effects of Pirfenidone on macrophage polarization and pulmonary fibrosis were evaluated in silicosis with early intervention and late treatment by histological examination, Enzyme-linked immunosorbent assay, Hydroxyproline assay, Western blot and Quantitative reverse transcription polymerase chain reaction." | 4.12 | Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling pathways. ( Bo, C; Jia, Q; Li, M; Tang, Q; Xing, C; Zhang, Z, 2022) |
| "In this study we investigated the protective effects and possible mechanisms of pirfenidone (PF) in paraquat (PQ)-induced lung injury and fibrosis in mice." | 3.88 | Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression. ( Ghazi-Khansari, M; Heidari, MR; Iranpour, M; Mandegary, A; Pourgholamhossein, F; Pourgholi, L; Pournamdari, M; Poursalehi, HR; Rasooli, R; Samareh-Fekri, M, 2018) |
| "Metabolites of arachidonic acid such as prostacyclin (PGI2) have been shown to participate in the pathogenesis of pulmonary fibrosis by inhibiting the expression of pro-inflammatory and pro-fibrotic mediators." | 3.76 | A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice. ( Gao, J; Guo, Z; Huang, K; Jiang, L; Liu, Y; Xiang, R; Xiao, Y; Zhou, W; Zhu, Y, 2010) |
| " To test the hypothesis that the absence of TIMP-1 enhances allergic lung inflammation, airway hyperreactivity (AHR), and lung remodeling in asthma, we studied TIMP-1 null (TIMP-1 KO) mice and their WT controls using an ovalbumin (OVA) asthma model." | 3.75 | Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. ( Aalinkeel, R; Blume, JW; Fang, YV; Knight, PR; Lachina, S; Mahajan, SD; Mullan, BA; Ohtake, PJ; Sands, MF; Schwartz, SA; Sykes, DE; Takyar, SS, 2009) |
| " This study examines the activity of the antioxidant N-acetylcysteine on bleomycin-induced pulmonary fibrosis in rats with emphasis on the early inflammatory phase." | 3.72 | In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. ( Blesa, S; Bulbena, O; Closa, D; Cortijo, J; Estrela, JM; Martinez-Losa, M; Morcillo, EJ; Prats, N; Serrano-Mollar, A, 2003) |
| " IL-12p40(-/-) mice treated with BLM intratracheally showed less pulmonary mononuclear cell inflammation at Day 7 than wild-type controls, whereas pulmonary fibrosis and hydroxyproline content were increased in IL-12p40(-/-) mice at Day 14." | 3.71 | IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis. ( Jain, F; Kradin, R; Sakamoto, H; Zhao, LH, 2002) |
| "The urinary excretion of collagen metabolites (hydroxylysine, hydroxyproline and proline) was significantly increased in 10 patients with cystic fibrosis and chronic broncho-pulmonary Pseudomonas aeruginosa infection as compared with 14 age matched controls." | 3.67 | Excretion of urinary collagen metabolites correlates to severity of pulmonary disease in cystic fibrosis. ( Ammitzbøll, T; Espersen, F; Pedersen, SS; Schiøler, H, 1988) |
| "MIA-602 reduced lung inflammation and fibrosis due to bleomycin." | 1.51 | Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin. ( Cai, R; Delcroix, G; Griswold, AJ; Jackson, RM; Lazerson, A; Mirsaeidi, M; Schally, AV; Wangpaichitr, M; Zhang, C, 2019) |
| "Pulmonary fibrosis is a disease with chronic inflammation and excessive collagen deposition for which there is no effective treatments." | 1.48 | Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice. ( Gao, Q; Jiang, W; Li, M; Li, Y; Peng, X; Xu, K; Yuan, X, 2018) |
| "A severe interstitial pneumonitis was evident histologically 15 days after BHT-treatment." | 1.27 | Enhanced acute lung damage following corticosteroid treatment. ( Kehrer, JP; Klein-Szanto, AJ; Pearlman, R; Rosner, MH; Sorensen, EM, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (29.79) | 18.7374 |
| 1990's | 6 (12.77) | 18.2507 |
| 2000's | 10 (21.28) | 29.6817 |
| 2010's | 15 (31.91) | 24.3611 |
| 2020's | 2 (4.26) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Song, M | 1 |
| Li, Z | 2 |
| Hou, L | 1 |
| Zhang, H | 1 |
| Zhang, Z | 2 |
| Hu, H | 1 |
| Jiang, X | 1 |
| Yang, J | 1 |
| Zou, X | 1 |
| Pang, J | 1 |
| Zhang, T | 1 |
| Yang, P | 1 |
| Wang, J | 2 |
| Wang, C | 1 |
| Tang, Q | 1 |
| Xing, C | 1 |
| Li, M | 2 |
| Jia, Q | 1 |
| Bo, C | 1 |
| Zhang, C | 1 |
| Cai, R | 1 |
| Lazerson, A | 1 |
| Delcroix, G | 1 |
| Wangpaichitr, M | 1 |
| Mirsaeidi, M | 1 |
| Griswold, AJ | 1 |
| Schally, AV | 1 |
| Jackson, RM | 1 |
| Pourgholamhossein, F | 1 |
| Rasooli, R | 1 |
| Pournamdari, M | 1 |
| Pourgholi, L | 1 |
| Samareh-Fekri, M | 1 |
| Ghazi-Khansari, M | 1 |
| Iranpour, M | 1 |
| Poursalehi, HR | 1 |
| Heidari, MR | 1 |
| Mandegary, A | 1 |
| Li, Y | 1 |
| Gao, Q | 1 |
| Xu, K | 1 |
| Peng, X | 1 |
| Yuan, X | 1 |
| Jiang, W | 1 |
| Lieber, GB | 1 |
| Fernandez, X | 1 |
| Mingo, GG | 1 |
| Jia, Y | 1 |
| Caniga, M | 1 |
| Gil, MA | 1 |
| Keshwani, S | 1 |
| Woodhouse, JD | 1 |
| Cicmil, M | 1 |
| Moy, LY | 1 |
| Kelly, N | 1 |
| Jimenez, J | 1 |
| Crawley, Y | 1 |
| Anthes, JC | 1 |
| Klappenbach, J | 1 |
| Ma, YL | 1 |
| McLeod, RL | 1 |
| Sueblinvong, V | 1 |
| Kerchberger, VE | 1 |
| Saghafi, R | 1 |
| Mills, ST | 1 |
| Fan, X | 1 |
| Guidot, DM | 1 |
| El-Agamy, DS | 1 |
| Sharawy, MH | 1 |
| Ammar, EM | 1 |
| Fu, Y | 1 |
| Rong, M | 1 |
| Zhu, P | 1 |
| Chen, L | 1 |
| Fan, C | 1 |
| Wang, Y | 1 |
| Li, J | 1 |
| Fu, X | 1 |
| Lei, L | 1 |
| He, ZY | 1 |
| Zhao, C | 1 |
| Sun, XJ | 1 |
| Zhong, XN | 1 |
| Chilakapati, SR | 1 |
| Serasanambati, M | 1 |
| Vissavajjhala, P | 1 |
| Kanala, JR | 1 |
| Chilakapati, DR | 1 |
| Valenca, SS | 1 |
| Silva Bezerra, F | 1 |
| Lopes, AA | 1 |
| Romana-Souza, B | 1 |
| Marinho Cavalcante, MC | 1 |
| Lima, AB | 1 |
| Gonçalves Koatz, VL | 1 |
| Porto, LC | 1 |
| Sands, MF | 1 |
| Ohtake, PJ | 1 |
| Mahajan, SD | 1 |
| Takyar, SS | 1 |
| Aalinkeel, R | 1 |
| Fang, YV | 1 |
| Blume, JW | 1 |
| Mullan, BA | 1 |
| Sykes, DE | 1 |
| Lachina, S | 1 |
| Knight, PR | 1 |
| Schwartz, SA | 1 |
| Sharaev, PN | 2 |
| Sakhabutdinov, EP | 1 |
| Lekomtseva, OI | 1 |
| Koshikova, SV | 1 |
| Zhu, Y | 1 |
| Liu, Y | 1 |
| Zhou, W | 1 |
| Xiang, R | 1 |
| Jiang, L | 1 |
| Huang, K | 1 |
| Xiao, Y | 1 |
| Guo, Z | 1 |
| Gao, J | 1 |
| Baowen, Q | 1 |
| Yulin, Z | 1 |
| Xin, W | 1 |
| Wenjing, X | 1 |
| Hao, Z | 1 |
| Zhizhi, C | 1 |
| Xingmei, D | 1 |
| Xia, Z | 2 |
| Yuquan, W | 1 |
| Lijuan, C | 1 |
| Song, L | 1 |
| Xu, J | 1 |
| Qu, J | 1 |
| Sai, Y | 1 |
| Chen, C | 1 |
| Yu, L | 1 |
| Li, D | 1 |
| Guo, X | 1 |
| Damazo, AS | 1 |
| Sampaio, AL | 1 |
| Nakata, CM | 1 |
| Flower, RJ | 1 |
| Perretti, M | 1 |
| Oliani, SM | 1 |
| Qiu, X | 1 |
| Ji, S | 1 |
| Li, H | 1 |
| Xia, T | 1 |
| Pan, B | 1 |
| Xiao, S | 1 |
| Mi, S | 1 |
| Liu, H | 1 |
| Hu, ZW | 1 |
| Hua, F | 1 |
| Serrano-Mollar, A | 2 |
| Closa, D | 2 |
| Prats, N | 2 |
| Blesa, S | 1 |
| Martinez-Losa, M | 1 |
| Cortijo, J | 2 |
| Estrela, JM | 1 |
| Morcillo, EJ | 2 |
| Bulbena, O | 2 |
| Lysov, AV | 1 |
| Nechaeva, GI | 1 |
| Vysokogorskiĭ, VE | 1 |
| Vasneva, SA | 1 |
| Vershinina, MV | 1 |
| Pritykina, TV | 1 |
| Pochetuhen, K | 1 |
| Luzina, IG | 1 |
| Lockatell, V | 1 |
| Choi, J | 1 |
| Todd, NW | 1 |
| Atamas, SP | 1 |
| Down, JD | 1 |
| Laurent, GJ | 1 |
| McAnulty, RJ | 1 |
| Steel, GG | 1 |
| Kehrer, JP | 1 |
| Klein-Szanto, AJ | 1 |
| Sorensen, EM | 1 |
| Pearlman, R | 1 |
| Rosner, MH | 1 |
| Garmash, VIa | 2 |
| Iakushin, SS | 3 |
| Panfilov, IuA | 1 |
| Osadchuk, MA | 1 |
| Tikhomirova, EI | 1 |
| Kosachevskaia, RTs | 1 |
| Osadchuk, TK | 1 |
| Quinlan, TR | 1 |
| BéruBé, KA | 1 |
| Marsh, JP | 1 |
| Janssen, YM | 1 |
| Taishi, P | 1 |
| Leslie, KO | 1 |
| Hemenway, D | 1 |
| O'Shaughnessy, PT | 1 |
| Vacek, P | 1 |
| Mossman, BT | 1 |
| Ortiz, LA | 1 |
| Lasky, JA | 1 |
| Safah, H | 1 |
| Reyes, M | 1 |
| Miller, A | 1 |
| Lungarella, G | 1 |
| Friedman, M | 1 |
| Xu, Z | 1 |
| Westrick, RJ | 1 |
| Shen, YC | 1 |
| Eitzman, DT | 1 |
| van Bree, L | 1 |
| Dormans, JA | 1 |
| Boere, AJ | 1 |
| Rombout, PJ | 1 |
| Sakamoto, H | 1 |
| Zhao, LH | 1 |
| Jain, F | 1 |
| Kradin, R | 1 |
| Gironella, M | 1 |
| Panés, J | 1 |
| Roselló-Catafau, J | 1 |
| Last, JA | 1 |
| Greenberg, DB | 1 |
| Castleman, WL | 1 |
| Shifrin, MA | 2 |
| Ceglecka-Tomaszewska, K | 1 |
| Iwańska, J | 1 |
| Tryczyńska, M | 1 |
| Chen, X | 1 |
| Botnikova, EA | 1 |
| Ivanov, VM | 1 |
| Zubarev, ON | 1 |
| Malinin, OV | 1 |
| Zubkova, SV | 1 |
| Wiessner, JH | 2 |
| Mandel, NS | 2 |
| Sohnle, PG | 2 |
| Hasegawa, A | 1 |
| Mandel, GS | 2 |
| Arsent'ev, FV | 1 |
| Shustov, SS | 1 |
| Barkov, VA | 1 |
| Namestnikov, VV | 1 |
| Hubbard, AK | 1 |
| Tetianets, SS | 2 |
| Henderson, JD | 1 |
| Ammitzbøll, T | 1 |
| Pedersen, SS | 1 |
| Espersen, F | 1 |
| Schiøler, H | 1 |
| Gembitskiĭ, EV | 1 |
| Motin, IuK | 1 |
| D'iachkova, AIa | 1 |
| Tsvetkova, EI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Double-Blind Placebo-Controlled Trial on the Safety and Efficacy of Imatinib for Hospitalized Adults With COVID-19[NCT04394416] | Phase 3 | 204 participants (Anticipated) | Interventional | 2020-06-02 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
47 other studies available for hydroxyproline and Pneumonia
| Article | Year |
|---|---|
FcεRI deficiency alleviates silica-induced pulmonary inflammation and fibrosis.
Topics: Animals; beta-N-Acetylhexosaminidases; Fibrosis; Histamine; Hydroxyproline; Immunoglobulin E; Interl | 2022 |
Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling pathways.
Topics: Animals; Fibrosis; Hydroxyproline; Interleukin-18; Janus Kinase 2; Macrophages; Pneumonia; Pulmonary | 2022 |
Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
Topics: Animals; Bleomycin; Cells, Cultured; Cytoprotection; Disease Models, Animal; Extracellular Signal-Re | 2019 |
Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Bronchoalveolar Lavage Fluid; Fibrosi | 2018 |
Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
Topics: Animals; Bleomycin; Collagen; Cytokines; Hydroxyproline; Interleukin-1; Mice; Pneumonia; Pulmonary F | 2018 |
Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models.
Topics: Animals; Bleomycin; Disease Models, Animal; Elasticity; Fibrosis; Hydroxyproline; Hypersensitivity; | 2013 |
Chronic alcohol ingestion primes the lung for bleomycin-induced fibrosis in mice.
Topics: Actins; Animals; Antibiotics, Antineoplastic; Bleomycin; Cell Differentiation; Central Nervous Syste | 2014 |
Agmatine attenuates silica-induced pulmonary fibrosis.
Topics: Agmatine; Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Cytoprotection; Disease Models, Animal; | 2014 |
[The circulating fibrocytes are associated with the lung inflammation and fibrosis of mice with interstitial lung disease].
Topics: Actins; Animals; Arthritis, Experimental; Bleomycin; Collagen Type I; Female; Flow Cytometry; Hydrox | 2014 |
Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Topics: Animals; Bleomycin; CD4-Positive T-Lymphocytes; Cell Differentiation; Cells, Cultured; Disease Model | 2016 |
Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
Topics: Actins; Animals; Anti-Inflammatory Agents; Bleomycin; Bosentan; Catalase; Collagen Type I; Collagen | 2015 |
Oxidative stress in mouse plasma and lungs induced by cigarette smoke and lipopolysaccharide.
Topics: Animals; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Catalase; Cell Count; Glutathione Per | 2008 |
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.
Topics: Animals; Asthma; Cytokines; Disease Models, Animal; Gene Expression; Hydroxyproline; Immunoglobulin | 2009 |
[A technique for determination of free and peptide-bound hydroxyproline in blood serum].
Topics: Adult; Benzaldehydes; Blood Chemical Analysis; Child; Child, Preschool; Chloramines; Female; Humans; | 2009 |
A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Bleomycin; Bronchoalveolar Lavage Fluid; Cytoki | 2010 |
A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis.
Topics: Animals; Bleomycin; Cytokines; Gene Expression Regulation; Hydroxyproline; Inflammation; Liposomes; | 2010 |
A therapeutic role for mesenchymal stem cells in acute lung injury independent of hypoxia-induced mitogenic factor.
Topics: Actins; Acute Lung Injury; Animals; Bone Marrow Cells; Cytokines; Fibrosis; Hydroxyproline; Intercel | 2012 |
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.
Topics: Animals; Annexin A1; Biomimetic Materials; Bleomycin; Cytokines; Disease Models, Animal; Epithelial | 2011 |
The therapeutic efficacy of Ulinastatin for rats with smoking inhalation injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Collagen Type I; | 2012 |
[Blocking IL-17A protects against lung injury-induced pulmonary fibrosis through promoting the activation of p50NF-kappaB].
Topics: Acute Lung Injury; Animals; Bleomycin; Collagen; Hydroxyproline; Interleukin-13; Interleukin-17; Mal | 2012 |
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
Topics: Acetonitriles; Acetylcysteine; Animals; Antioxidants; Biomarkers; Bleomycin; Bronchoalveolar Lavage | 2003 |
[Connective tissue metabolic parameters in differential diagnosis of infiltrative pulmonary tuberculosis and pneumonia in patients with signs of connective tissue dysplasia].
Topics: Connective Tissue; Connective Tissue Diseases; Cross Infection; Diagnosis, Differential; Glycosamino | 2003 |
Complex regulation of pulmonary inflammation and fibrosis by CCL18.
Topics: Adenoviridae; Animals; Antibiotics, Antineoplastic; Antigens, CD; Bleomycin; Cells, Cultured; Chemok | 2007 |
Oxygen-dependent protection of radiation lung damage in mice by WR 2721.
Topics: Amifostine; Animals; Dose-Response Relationship, Radiation; Hair; Hydroxyproline; Lung; Male; Mice; | 1984 |
Enhanced acute lung damage following corticosteroid treatment.
Topics: Acute Disease; Animals; Butylated Hydroxytoluene; DNA; Hydroxyproline; Lung; Lung Diseases; Male; Me | 1984 |
[Oxyproline determination in acute and chronic pneumonia].
Topics: Adolescent; Adult; Aged; Diagnosis, Computer-Assisted; Free Radicals; Humans; Hydroxyproline; Middle | 1980 |
[Possibilities of early diagnosis of protracted pneumonia and its transition to the chronic form].
Topics: Chronic Disease; Glycoproteins; Humans; Hydroxyproline; Male; Middle Aged; Mucoproteins; Pneumonia; | 1981 |
Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos.
Topics: Administration, Inhalation; Animals; Asbestos, Serpentine; Bromodeoxyuridine; Bronchoalveolar Lavage | 1995 |
Exacerbation of bleomycin-induced lung injury in mice by amifostine.
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Bleomycin; Collagen; Female; Fibrosis; Gene Expres | 1999 |
Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injury.
Topics: Activated Protein C Resistance; Animals; Bleomycin; Disease Models, Animal; Factor V; Hydroxyproline | 2001 |
Time study on development and repair of lung injury following ozone exposure in rats.
Topics: Albumins; Animals; Bronchoalveolar Lavage Fluid; Cell Differentiation; DNA; Hydroxyproline; Leukocyt | 2001 |
IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Bronchoalveolar Lavage Fluid; Chemokine CCL11; Chemokine | 2002 |
P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine.
Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Bleomycin; Hydroxyproline; Immunohistochemistr | 2002 |
Ozone-induced alterations in collagen metabolism of rat lungs.
Topics: Animals; Collagen; Hydroxyproline; Lung; Male; Ozone; Pneumonia; Proline; Rats; Time Factors | 1979 |
[Hydroxyproline as an indicator of the process activity in inflammatory lung diseases].
Topics: Acute Disease; Adult; Aged; Bronchitis; Chronic Disease; Humans; Hydroxyproline; Middle Aged; Pneumo | 1977 |
[Study of hydroxyproline metabolism in inflammatory lung diseases].
Topics: Acute Disease; Adolescent; Adult; Aged; Asthma; Chronic Disease; Humans; Hydroxyproline; Middle Aged | 1978 |
[Urinary excretion of hydroxyproline in children with respiratory diseases].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Female; Humans; Hydroxyproline; Infant; Male; Pneu | 1975 |
[Protective effect of 764-3 on experimental lung fibrosis in rats].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Drug Combinations; Drugs, Chinese Herba | 1992 |
[The determination of free and bound oxyproline in urine].
Topics: Adult; Child, Preschool; Hemorrhagic Fever with Renal Syndrome; Humans; Hydroxyproline; Infant; Pept | 1990 |
The effect of chemical modification of quartz surfaces on particulate-induced pulmonary inflammation and fibrosis in the mouse.
Topics: Animals; Hemolysis; Hydroxyproline; Lung; Male; Mice; Mice, Inbred C57BL; Pneumonia; Pulmonary Fibro | 1990 |
[Various indicators of early diagnosis of the protracted course of acute pneumonia].
Topics: Acute Disease; Adult; Female; Haptoglobins; Humans; Hydroxyproline; Immunoglobulins; Male; Middle Ag | 1990 |
Role for T lymphocytes in silica-induced pulmonary inflammation.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Count; Collagen; Hydroxyproline; Mice; Peptidyl-Dipeptid | 1989 |
[Method of determining free oxyproline in blood].
Topics: Adult; Humans; Hydroxyproline; Middle Aged; Pneumonia; Reference Values | 1985 |
The effect of crystal structure on mouse lung inflammation and fibrosis.
Topics: Animals; Crystallization; Hemolysis; Hydroxyproline; Lung; Mice; Mice, Inbred C57BL; Models, Molecul | 1988 |
Excretion of urinary collagen metabolites correlates to severity of pulmonary disease in cystic fibrosis.
Topics: Adolescent; Adult; Bronchitis; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Hydroxylys | 1988 |
[Serum elastase, proelastase and free hydroxyproline in acute pneumonia].
Topics: Acute Disease; Adolescent; Adult; Enzyme Precursors; Female; Humans; Hydroxyproline; Male; Middle Ag | 1986 |
[Hydroxyproline excretion and serum hyaluronidase activity in older children with chronic non-specific pneumonia].
Topics: Adolescent; Child; Chronic Disease; Female; Humans; Hyaluronoglucosaminidase; Hydroxyproline; Male; | 1972 |